NCT00391170View on ClinicalTrials.gov

Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

November 24, 2006

Primary Completion Date

February 1, 2021

Study Completion Date

February 1, 2021

Conditions
Graft vs Host Disease
Interventions
DRUG

Topical Dexamethasone

dexamethasone 0.01%

DRUG

Placebo

Placebo

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00391170 - Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease | Biotech Hunter | Biotech Hunter